Desjardins Global Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Desjardins Global Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$767K	Sell
2023 Q3	$1.12M	Sell
2023 Q2	$1.6M	Sell
2023 Q1	$2.26M	Sell
2022 Q4	$2.7M	Sell
2022 Q3	$3.35M	Buy
2022 Q2	$2.87M	Sell
2022 Q1	$4.02M	Sell
2021 Q4	$5.94M	Buy